Drugs / Docosanol
last change Nov 2025 re-read 2 minutes ago

Docosanol

Small molecule

Developed for
herpes labialis
Investigated by
Hadassah Medical Organization

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) ABREVA 2000-07-25 fda.gov

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00467662 herpes labialis Hadassah Medical Organization Unknown No outcome recorded
Also used as a comparator or background therapy in 3 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06558838 Comparator Aug 2024 → Nov 2025 herpes labialis University of Utah Completed No outcome recorded
Phase 2 NCT04893577 Comparator Jan 2022 → Aug 2024 herpes labialis University of Utah Completed No outcome recorded
Phase 2 NCT03977792 Comparator Sep 2020 → Jul 2021 herpes labialis Laboratoire Boreaderme Inc. Unknown No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Docosanol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00467662
1

NCT03977792

Known as Abreva ClinicalTrials.gov intervention name — accepted as the source's own label NCT06558838
1

NCT04893577

Known as Behenic alcohol ChEMBL registry synonym — accepted as the source's own label CHEMBL1200453
Known as Behenyl alcohol ChEMBL registry synonym — accepted as the source's own label CHEMBL1200453
Known as Lidakol ChEMBL registry synonym — accepted as the source's own label CHEMBL1200453
Known as N-docosanol ChEMBL registry synonym — accepted as the source's own label CHEMBL1200453
Known as NSC-8407 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200453
Known as Stenol 1822 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200453
Modality Small molecule CHEMBL1200453